Canopy Growth Corp
CGC
查看详细走势图
1.425USD
+0.105+7.95%
交易中 （美东）报价延迟15分钟
473.64M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+7.95%
5天
-14.16%
1月
+28.38%
6月
+14.92%
今年开始到现在
-47.99%
1年
-49.65%
查看详细走势图
TradingKey Canopy Growth Corp股票评分
单位: USD 更新时间: 2025-12-22操作建议
Canopy Growth Corp当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在药品行业排名87/158位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价3.65。中期看，股价处于平稳状态。近一个月，市场表现很强，技术面和基本面综合得分较高，很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
Canopy Growth Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
1
位分析师
持有
评级
3.650
目标均价
+234.86%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Canopy Growth Corp亮点
亮点风险
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
估值合理
公司最新PE估值-0.69，处于3年历史合理位
机构减仓
最新机构持股38.22M股，环比减少0.04%
活跃度增加
近期活跃度增加，过去20天平均换手率0.73
Canopy Growth Corp新闻
-31b44ed233cc403f81d95a352e2f11a8.jpg)
.jpg)
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Canopy Growth Corp简介
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
公司代码CGC
公司Canopy Growth Corp
CEOMongeau (Luc)
网址https://www.canopygrowth.com/
常见问题
Canopy Growth Corp(CGC)的当前股价是多少？
Canopy Growth Corp(CGC)的当前股价是 1.425。
Canopy Growth Corp的股票代码是什么？
Canopy Growth Corp的股票代码是CGC。
Canopy Growth Corp股票的52周最高点是多少？
Canopy Growth Corp股票的52周最高点是4.410。
Canopy Growth Corp股票的52周最低点是多少？
Canopy Growth Corp股票的52周最低点是1.085。
Canopy Growth Corp的市值是多少？
Canopy Growth Corp的市值是473.64M。
Canopy Growth Corp的净利润是多少？
Canopy Growth Corp的净利润为-598.12M。
现在Canopy Growth Corp(CGC)的股票是买入、持有还是卖出？
根据分析师评级，Canopy Growth Corp(CGC)的总体评级为持有，目标价格为3.650。
Canopy Growth Corp(CGC)股票的每股收益（EPS TTM）是多少
Canopy Growth Corp(CGC)股票的每股收益（EPS TTM）是-1.920。
相关品种
